130 related articles for article (PubMed ID: 38748071)
1. Differential Gene Analysis of Langerhans Cell Histiocytosis and the Significance of MMP1-Targeted Drug Repositioning.
Feng X; Yuan X; Hua YY; Tao J; Zhang N
Mol Biotechnol; 2024 May; ():. PubMed ID: 38748071
[TBL] [Abstract][Full Text] [Related]
2. Detection of Immune Microenvironment Changes and Immune-Related Regulators in Langerhans Cell Histiocytosis Bone Metastasis.
Lin J; Tang H; Xu Z; Zeng R
Biomed Res Int; 2023; 2023():1447435. PubMed ID: 36714021
[TBL] [Abstract][Full Text] [Related]
3. Clinical and prognostic characteristics of 95 cases of Langerhans cell histiocytosis in children: a single-institute experience from 2013 to 2020.
Tang X; Gao J; Ma ZG; Guo X; Li Q; Wan Z; Sun JJ
Ann Med; 2021 Dec; 53(1):1537-1546. PubMed ID: 34459688
[TBL] [Abstract][Full Text] [Related]
4. Somatic ARAF mutations in pediatric Langerhans cell histiocytosis: clinicopathologic, genetic and functional profiling.
Liu R; Guo Y; Han L; Feng S; Cao J; Sun Y; Cao Z; Cui X
Clin Exp Med; 2023 Dec; 23(8):5269-5279. PubMed ID: 37572153
[TBL] [Abstract][Full Text] [Related]
5. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis.
Li C; Lu Y; Han X
Front Mol Biosci; 2022; 9():917077. PubMed ID: 35911963
[No Abstract] [Full Text] [Related]
6. Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis.
Halbritter F; Farlik M; Schwentner R; Jug G; Fortelny N; Schnöller T; Pisa H; Schuster LC; Reinprecht A; Czech T; Gojo J; Holter W; Minkov M; Bauer WM; Simonitsch-Klupp I; Bock C; Hutter C
Cancer Discov; 2019 Oct; 9(10):1406-1421. PubMed ID: 31345789
[TBL] [Abstract][Full Text] [Related]
7. The commonness in immune infiltration of rheumatoid arthritis and atherosclerosis: Screening for central targets
Wang Z; Xia Q; Su W; Zhang M; Gu Y; Xu J; Chen W; Jiang T
Front Immunol; 2022; 13():1013531. PubMed ID: 36311761
[TBL] [Abstract][Full Text] [Related]
8. IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy.
Murakami I; Morimoto A; Oka T; Kuwamoto S; Kato M; Horie Y; Hayashi K; Gogusev J; Jaubert F; Imashuku S; Al-Kadar LA; Takata K; Yoshino T
Virchows Arch; 2013 Feb; 462(2):219-28. PubMed ID: 23269323
[TBL] [Abstract][Full Text] [Related]
9. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.
Allen CE; Li L; Peters TL; Leung HC; Yu A; Man TK; Gurusiddappa S; Phillips MT; Hicks MJ; Gaikwad A; Merad M; McClain KL
J Immunol; 2010 Apr; 184(8):4557-67. PubMed ID: 20220088
[TBL] [Abstract][Full Text] [Related]
10. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
[TBL] [Abstract][Full Text] [Related]
11. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
12.
Ozer E; Sevinc A; Ince D; Yuzuguldu R; Olgun N
Pediatr Dev Pathol; 2019 Oct; 22(5):449-455. PubMed ID: 31072207
[TBL] [Abstract][Full Text] [Related]
13. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis.
Rust R; Kluiver J; Visser L; Harms G; Blokzijl T; Kamps W; Poppema S; van den Berg A
J Pathol; 2006 Aug; 209(4):474-83. PubMed ID: 16718746
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.
Murakami I; Oka T; Kuwamoto S; Kato M; Hayashi K; Gogusev J; Imamura T; Morimoto A; Imashuku S; Yoshino T
Virchows Arch; 2011 Aug; 459(2):227-34. PubMed ID: 21604205
[TBL] [Abstract][Full Text] [Related]
15. Gene crosstalk between COVID-19 and preeclampsia revealed by blood transcriptome analysis.
Chu Y; Li M; Sun M; Wang J; Xin W; Xu L
Front Immunol; 2023; 14():1243450. PubMed ID: 38259479
[TBL] [Abstract][Full Text] [Related]
16. New insights into the molecular pathogenesis of langerhans cell histiocytosis.
Rizzo FM; Cives M; Simone V; Silvestris F
Oncologist; 2014 Feb; 19(2):151-63. PubMed ID: 24436311
[TBL] [Abstract][Full Text] [Related]
17. Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis.
Jouenne F; Benattia A; Tazi A
Curr Opin Oncol; 2021 Mar; 33(2):101-109. PubMed ID: 33315630
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol].
Huang JB; Xue HM; Chen YY; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):146-9. PubMed ID: 23484709
[TBL] [Abstract][Full Text] [Related]
19. Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.
Hutter C; Minkov M
Immunotargets Ther; 2016; 5():81-91. PubMed ID: 27785447
[TBL] [Abstract][Full Text] [Related]
20. Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.
Minkov M
Paediatr Drugs; 2011 Apr; 13(2):75-86. PubMed ID: 21351807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
